Prevention of fat-induced insulin resistance by salicylate

Journal of Clinical Investigation

Volumn 108, Issue 3, 2001, Pages 437-446

  Kim, Jason K ^a   Kim, Yoon Jung ^a   Fillmore, Jonathan J ^a   Chen, Yan ^a   Moore, Irene ^a   Lee, Jongsoon ^b   Yuan, Minsheng ^b   Li, Zhi Wei ^c   Karin, Michael ^c   Perret, Pascale ^a   Shoelson, Steven E ^b   Shulman, Gerald I ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; INSULIN; LIPOSYN II; SALICYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 0034903710     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI11559     Document Type: Article

References (46)

1. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM
2. Role of insulin resistance in human disease
3. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
4. The glucose fatty acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
5. Interaction between glucose and free fatty, acid metabolism in human skeletal muscle
6. Effects of starvation and exercise on concentrations of citrate, hexose phosphates, and glycogen in skeletal muscle and heart: Evidence for selective operation of the glucose-fatty acid cycle
7. Glucose-fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations
8. Mechanism of free fatty acid-induced insulin resistance in humans
9. Effect of free fatty acids on IRS-1 associated PI 3-kinase activity
10. Free fatty acid-induced insulin resistance is associated with activation of protein kinase Cθ and alterations in the insulin signaling cascade
11. Molecular mechanisms of insulin action in normal and insulin-resistant states
12. On the treatment of glycosuria and diabetes mellitus with sodium salicylate
13. Aspirin and diabetes mellitus
14. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
15. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats
16. Reversal of obesity and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ
17. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice
18. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and ω-3 fatty acids in muscle phospholipid
19. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake
20. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
21. Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle
22. Insulin signaling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice
23. Insulin action, diabetogenes, and the cause of type II diabetes
24. Alteration of insulin-receptor kinase activity, by high fat feeding
25. Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat
26. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rats
27. Mechanisms of TNF-alpha-induced insulin resistance
28. 307 via distinct pathways
29. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance
30. Tumor necrosis factor-αinduced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction
31. Persistent activation of phosphatidylinositol 3kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes
32. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
33. Regulation of the insulin signaling pathway by cellular protein-tyrosine phosphatases
34. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation
35. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide
36. Insulin increases the association of Akt-2 with Glut4-containing vesicles
37. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
38. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation
39. Nuclear factor-κB-A pivotal transcription factor in chronic inflammatory diseases
40. Tumor necrosis factor-α acutely inhibits insulin signaling in human adipocytes
41. Tumor necrosis factor α: A key component of the obesity-diabetes link
42. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1
43. Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate-1 to phosphatidylinesitol 3-kinase in 3T3-L1 adipocytes
44. Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein and NF-kappa B-responsive genes
45. Modes of action of aspirin-like drugs: Salicylates inhibit etk activation and integtin-dependent neutrophil adhesion
46. Inhibition of IκB kinase activity, by sodium salicylate in vitro does not reflect its inhibitory mechanism in intact cells